Related Experiment Video
Updated: Sep 25, 2026

Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate
Published on: February 22, 2020
Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine
Christian Theilacker1, Fadie T Coleman, Simone Mueschenborn
1Channing Laboratory, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115-5804, USA.
Abstract:
Deterioration of lung function in patients with cystic fibrosis (CF) is closely associated with chronic pulmonary infection with mucoid Pseudomonas aeruginosa. The mucoid exopolysaccharide (MEP) from P. aeruginosa has been shown to induce opsonic antibodies in mice that are protective against this chronic infection. MEP-specific opsonic antibodies are also commonly found in the sera of older CF patients lacking detectable P. aeruginosa infection. When used in a human vaccine trial, however, MEP only minimally induced opsonic antibodies. To evaluate whether conjugation of MEP to a carrier protein could improve its immunogenicity, we bound thiolated MEP to keyhole limpet hemocyanin (KLH) by using succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) as a linker. In contrast to the native MEP polymer, the MEP-KLH conjugate vaccine induced high titers of MEP-specific immunoglobulin G (IgG) in C3H-HeN mice and in a rabbit. Sera from mice immunized with MEP-KLH conjugate, but not from animals immunized with comparable doses of native MEP, demonstrated opsonic killing activity. Vaccination with MEP-KLH conjugate induced opsonic antibodies broadly cross-reactive to heterologous mucoid strains of P. aeruginosa. Preexisting nonopsonic antibodies to MEP are found in normal human sera, including young CF patients, and their presence impedes the induction of opsonic antibodies. Induction of nonopsonic antibodies by either intraperitoneal injection of MEP or injection or feeding of the cross-reactive antigen, seaweed alginate, reduced the level of overall IgG elicited by follow-up immunization with the MEP-KLH conjugate. However, the opsonic activity was lower only in the sera of MEP-KLH conjugate-immunized mice with preexisting antibodies induced by MEP but not with antibodies induced by seaweed alginate. Immunization with MEP-KLH elicited a significant proportion of antibodies specific to epitopes involving O-acetate residues, and this subpopulation of antibodies mediated opsonic killing of mucoid P. aeruginosa in vitro. These results indicate that conjugation of MEP to KLH significantly enhances its immunogenicity and the elicitation of opsonic antibodies in mice and rabbits, that the conjugate induces opsonic antibodies in the presence of preexisting nonopsonic antibodies, and that opsonic antibodies to MEP are directed at epitopes that include acetate residues on the uronic acid polymer.
Insights
Conjugating mucoid exopolysaccharide (MEP) from Pseudomonas aeruginosa to a carrier protein (KLH) significantly boosts the immune response, generating protective opsonic antibodies crucial for fighting CF lung infections.
Area of Science:
- Immunology
- Microbiology
- Vaccine Development
Background:
- Cystic Fibrosis (CF) lung function decline is linked to chronic Pseudomonas aeruginosa infection.
- Mucoid exopolysaccharide (MEP) from P. aeruginosa can induce protective opsonic antibodies, but its direct use in vaccines is minimally effective.
Purpose of the Study:
- To enhance the immunogenicity of MEP by conjugating it to a carrier protein (KLH).
- To evaluate the efficacy of the MEP-KLH conjugate in inducing opsonic antibodies against mucoid P. aeruginosa.
Main Methods:
- Thiolated MEP was conjugated to keyhole limpet hemocyanin (KLH) using SMCC linker.
- Immunogenicity and opsonic activity of the MEP-KLH conjugate were assessed in mice and rabbits.
- The impact of pre-existing antibodies on the immune response was investigated.
Main Results:
- MEP-KLH conjugate induced high titers of MEP-specific IgG and significant opsonic killing activity in mice and rabbits.
- The conjugate elicited broadly cross-reactive opsonic antibodies against heterologous mucoid P. aeruginosa strains.
- Antibodies targeting O-acetate residues on MEP were identified as mediating opsonic killing.
Conclusions:
- Conjugation of MEP to KLH dramatically improves its immunogenicity and ability to elicit protective opsonic antibodies.
- The MEP-KLH conjugate vaccine is effective in inducing opsonic antibodies, even in the presence of pre-existing non-opsonic antibodies.
- Targeting acetate residues on MEP holds promise for developing effective vaccines against mucoid P. aeruginosa infections in CF patients.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
08:57Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis
Published on: March 10, 2014